Literature DB >> 12784878

FAK signaling in anaplastic astrocytoma and glioblastoma tumors.

Meera Natarajan1, Timothy P Hecker, Candece L Gladson.   

Abstract

Focal adhesion kinase (FAK) is a non-receptor cytoplasmic-tyrosine kinase that is activated by several different cell surface receptors shown to be upregulated on glioblastoma cells (integrins alpha(v)beta3 and alpha(v)beta5, and the epidermal growth factor receptor). Activated FAK can signal through several different signaling pathways, which are reviewed here. Published data are summarized that have demonstrated 1) elevated FAK expression in anaplastic astrocytoma and glioblastoma tumor biopsy samples, 2) a role for FAK in the promotion of glioblastoma cell proliferation, survival and migration in vitro, and 3) a role for FAK in the promotion of glioblastoma cell proliferation in vivo in an animal model. The available data suggests that increased levels of FAK protein and activity may contribute to an increased ERK activity and cell proliferation in vivo in these tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12784878     DOI: 10.1097/00130404-200303000-00008

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  41 in total

1.  PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts.

Authors:  Hongbo Chen; Lin Mei; Lanzhen Zhou; Xiaomeng Shen; Caiping Guo; Yi Zheng; Huijun Zhu; Yongqiang Zhu; Laiqiang Huang
Journal:  J Neurooncol       Date:  2010-12-29       Impact factor: 4.130

2.  PDGFR inhibition mediated intracellular signalling in C6 glioma growth and migration: role of ERK and ROCK pathway.

Authors:  Juhi Singh; Kedarlal Sharma; Prakash P Pillai
Journal:  Cytotechnology       Date:  2017-11-15       Impact factor: 2.058

3.  In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation.

Authors:  Markus J Riemenschneider; Wolf Mueller; Rebecca A Betensky; Gayatry Mohapatra; David N Louis
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

4.  Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1.

Authors:  Urai Pongchairerk; Jun-Lin Guan; Vijittra Leardkamolkarn
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

5.  Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy.

Authors:  Fadila Guessous; Yanzhi Yang; Elizabeth Johnson; Lukasz Marcinkiewicz; Matthew Smith; Ying Zhang; Alexander Kofman; David Schiff; James Christensen; Roger Abounader
Journal:  Mol Cancer Ther       Date:  2011-12-21       Impact factor: 6.261

6.  PTEN suppresses SPARC-induced pMAPKAPK2 and inhibits SPARC-induced Ser78 HSP27 phosphorylation in glioma.

Authors:  Ridwan Alam; Chad R Schultz; William A Golembieski; Laila M Poisson; Sandra A Rempel
Journal:  Neuro Oncol       Date:  2013-02-03       Impact factor: 12.300

7.  Kinomic exploration of temozolomide and radiation resistance in Glioblastoma multiforme xenolines.

Authors:  Joshua C Anderson; Christine W Duarte; Karim Welaya; Timothy D Rohrbach; Markus Bredel; Eddy S Yang; Nirmal V Choradia; Jaideep V Thottassery; George Yancey Gillespie; James A Bonner; Christopher D Willey
Journal:  Radiother Oncol       Date:  2014-05-08       Impact factor: 6.280

8.  TWIST1 promotes invasion through mesenchymal change in human glioblastoma.

Authors:  Svetlana A Mikheeva; Andrei M Mikheev; Audrey Petit; Richard Beyer; Robert G Oxford; Leila Khorasani; John-Patrick Maxwell; Carlotta A Glackin; Hiroaki Wakimoto; Inés González-Herrero; Isidro Sánchez-García; John R Silber; Philip J Horner; Robert C Rostomily
Journal:  Mol Cancer       Date:  2010-07-20       Impact factor: 27.401

9.  Mesenchymal migration as a therapeutic target in glioblastoma.

Authors:  Jessie Zhong; Andre Paul; Stewart J Kellie; Geraldine M O'Neill
Journal:  J Oncol       Date:  2010-06-21       Impact factor: 4.375

Review 10.  Galectins and gliomas.

Authors:  Marie Le Mercier; Shannon Fortin; Véronique Mathieu; Robert Kiss; Florence Lefranc
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.